Ash Stevens a subsidiary of Piramal Pharma Solutions Revenue and Competitors
Estimated Revenue & Valuation
- Ash Stevens a subsidiary of Piramal Pharma Solutions's estimated annual revenue is currently $57.7M per year.
- Ash Stevens a subsidiary of Piramal Pharma Solutions's estimated revenue per employee is $201,000
Employee Data
- Ash Stevens a subsidiary of Piramal Pharma Solutions has 287 Employees.
- Ash Stevens a subsidiary of Piramal Pharma Solutions grew their employee count by -1% last year.
Ash Stevens a subsidiary of Piramal Pharma Solutions's People
Name | Title | Email/Phone |
---|
Ash Stevens a subsidiary of Piramal Pharma Solutions Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $67.1M | 267 | 6% | $10.8M | N/A |
#2 | $7.8M | 39 | 8% | N/A | N/A |
#3 | $5M | 25 | 4% | N/A | N/A |
#4 | $12.7M | 63 | -6% | N/A | N/A |
#5 | $16.5M | 82 | -4% | N/A | N/A |
#6 | $59.5M | 296 | 7% | N/A | N/A |
#7 | $96.2M | 342 | 29% | $764.2M | N/A |
#8 | $6.8M | 34 | 10% | N/A | N/A |
#9 | $5.4M | 27 | -4% | N/A | N/A |
#10 | $8.2M | 41 | 5% | N/A | N/A |
What Is Ash Stevens a subsidiary of Piramal Pharma Solutions?
Ash Stevens Inc. is a full-service Contract Pharmaceutical Manufacturer offering comprehensive small-molecule drug substance development and cGMP manufacturing services. Founded in 1962 and headquartered in Riverview, Michigan, Ash Stevens has extensive experience developing and manufacturing Active Pharmaceutical Ingredients (APIs) for commercial clients in the Life Sciences industry developing innovator small-molecule drugs. Our business model is predicated on providing Sponsor clients with the safest and highest quality work product possible while meeting delivery obligations on time and on budget.
keywords:N/AN/A
Total Funding
287
Number of Employees
$57.7M
Revenue (est)
-1%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $52.9M | 423 | 10% | N/A |
#2 | $221.9M | 503 | 36% | N/A |
#3 | $335.4M | 769 | 5% | $255M |
#4 | $326.6M | 1111 | N/A | N/A |